Loading...
InMode Ltd.
INMD•NASDAQ
Healthcare
Medical - Devices
$14.72
$0.19(1.31%)
InMode Ltd. (INMD) Financial Performance & Income Statement Overview
Review InMode Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-19.76%
↓ 19.76%
Operating Income Growth
-42.49%
↓ 42.49%
Net Income Growth
-8.41%
↓ 8.41%
Operating Cash Flow Growth
-24.97%
↓ 24.97%
Operating Margin
28.05%
↑ 28.05%
Gross Margin
80.03%
↑ 80.03%
Net Profit Margin
44.80%
↑ 44.80%
ROE
25.01%
↑ 25.01%
ROIC
17.41%
↑ 17.41%
InMode Ltd. (INMD) Income Statement & Financial Overview
Review InMode Ltd.'s (INMD) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $97.85M | $130.23M | $86.45M | $80.28M |
| Cost of Revenue | $20.22M | $24.05M | $17.12M | $16.36M |
| Gross Profit | $77.64M | $106.18M | $69.33M | $63.92M |
| Gross Profit Ratio | $0.79 | $0.82 | $0.80 | $0.80 |
| R&D Expenses | $2.67M | $3.25M | $3.70M | $3.52M |
| SG&A Expenses | $47.11M | $54.66M | $47.32M | $42.31M |
| Operating Expenses | $49.77M | $57.92M | $51.02M | $45.83M |
| Total Costs & Expenses | $69.99M | $81.97M | $68.14M | $62.19M |
| Interest Income | $0.00 | $9.92M | $8.69M | $7.98M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $248000.00 | $138000.00 | $177000.00 | $165000.00 |
| EBITDA | $28.11M | $48.40M | $18.49M | $18.26M |
| EBITDA Ratio | $0.29 | $0.37 | $0.21 | $0.23 |
| Operating Income | $27.86M | $48.26M | $18.31M | $18.09M |
| Operating Income Ratio | $0.28 | $0.37 | $0.21 | $0.23 |
| Other Income/Expenses (Net) | $4.35M | $9.92M | $8.69M | $7.98M |
| Income Before Tax | $32.21M | $58.18M | $27.004M | $26.08M |
| Income Before Tax Ratio | $0.33 | $0.45 | $0.31 | $0.32 |
| Income Tax Expense | -$50.56M | $7.19M | $3.19M | $2.38M |
| Net Income | $82.77M | $50.99M | $23.82M | $23.70M |
| Net Income Ratio | $0.85 | $0.39 | $0.28 | $0.30 |
| EPS | $1.15 | $0.66 | $0.28 | $0.28 |
| Diluted EPS | $1.14 | $0.65 | $0.28 | $0.28 |
| Weighted Avg Shares Outstanding | $71.87M | $77.02M | $83.88M | $84.52M |
| Weighted Avg Shares Outstanding (Diluted) | $72.79M | $78.55M | $85.89M | $85.97M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan